Yuka Aimono

Hitachi, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Atypical Femoral Fracture During Long-Term Treatment With Denosumab in Patients With Metastatic Bone Tumors.

Atypical Femoral Fracture During Long-Term Treatment With Denosumab in Patients With Metastatic Bone Tumors.

Journal: Cureus
Published: May 28, 2025

Atypical Femoral Fracture in Patients With Metastatic Bone Tumors: An Analysis Based on the Japanese Adverse Drug Event Reaction Database (JADER).

Atypical Femoral Fracture in Patients With Metastatic Bone Tumors: An Analysis Based on the Japanese Adverse Drug Event Reaction Database (JADER).

Journal: Cureus
Published: May 02, 2025

A Case of Liver Injury Immediately After Initiation of Triple Therapy in a Patient With BRAF V600E Mutation-Positive Colorectal Cancer.

A Case of Liver Injury Immediately After Initiation of Triple Therapy in a Patient With BRAF V600E Mutation-Positive Colorectal Cancer.

Journal: Cureus
Published: August 15, 2024

Colitis Suggested to be Related to Nivolumab in a Gastric Cancer Patient with a History of Ulcerative Colitis: A Case Report

Colitis Suggested to be Related to Nivolumab in a Gastric Cancer Patient with a History of Ulcerative Colitis: A Case Report

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: January 31, 2024

Side Effect Management in the Early Stages of Cabozantinib Administration

Side Effect Management in the Early Stages of Cabozantinib Administration

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: October 17, 2021

Evaluation of Risk Factors for Immune-Related Adverse Events Associated with Treatment with Immune Checkpoint Inhibitors

Evaluation of Risk Factors for Immune-Related Adverse Events Associated with Treatment with Immune Checkpoint Inhibitors

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 20, 2021

Factors associated with a reduction in the quality of life of patients with chronic hepatitis C treated by ledipasvir/sofosbuvir therapy.

Factors associated with a reduction in the quality of life of patients with chronic hepatitis C treated by ledipasvir/sofosbuvir therapy.

Journal: European journal of hospital pharmacy : science and practice
Published: January 15, 2020

QOL Assessment in Chronic Hepatitis C Patients Receiving Ledipasvir/ Sofosbuvir or Simeprevir/Peginterferon/Ribavirin in Clinical Practice

QOL Assessment in Chronic Hepatitis C Patients Receiving Ledipasvir/ Sofosbuvir or Simeprevir/Peginterferon/Ribavirin in Clinical Practice

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: November 06, 2019

A Case of Rectal Cancer and Multiple Liver Metastases Treated Using mFOLFOX and Bevacizumab under Maintenance Dialysis

A Case of Rectal Cancer and Multiple Liver Metastases Treated Using mFOLFOX and Bevacizumab under Maintenance Dialysis

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 21, 2018

Impact of Physician Order Support Duties on de novo Hepatitis Prevention

Impact of Physician Order Support Duties on de novo Hepatitis Prevention

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 21, 2018

Team Approaches for and Future Challenges to Promoting Perioperative Oral Management

Team Approaches for and Future Challenges to Promoting Perioperative Oral Management

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: April 13, 2016

Initial Evaluation of the Efficacy and Safety of Tablets Containing Trifluridine and Tipiracil Hydrochloride--Safety Measures Devised by a Multidisciplinary Team Including a Pharmaceutical Outpatient Clinic

Initial Evaluation of the Efficacy and Safety of Tablets Containing Trifluridine and Tipiracil Hydrochloride--Safety Measures Devised by a Multidisciplinary Team Including a Pharmaceutical Outpatient Clinic

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 23, 2015
Showing 1-12 of 17

Last Updated: 09/26/2026